PMEDF (QScreen AI) Financial Strength: 0 (As of Jan. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is QScreen AI Financial Strength?

QScreen AI has the Financial Strength Rank of 0.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is rated on a scale of 1 to 10 and is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.
4. Other debt related ratios.

A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.

QScreen AI has no long-term debt (1). As of today, QScreen AI's Altman Z-Score is 0.00.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.


QScreen AI  (OTCPK:PMEDF) Financial Strength Explanation

The rank is rated on a scale of 1 to 10. A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.

QScreen AI has the Financial Strength Rank of 0.


QScreen AI Financial Strength Related Terms


PMEDF vs ABT, SYK, MDT: Financial Strength Comparison

For the Medical Devices subindustry, QScreen AI's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QScreen AI Financial Strength vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, QScreen AI's Financial Strength distribution charts can be found below:

* The bar in red indicates where QScreen AI's Financial Strength falls into.



QScreen AI Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

QScreen AI's Interest Expense for the months ended in Jan. 2026 was $0.00 Mil. Its Operating Income for the months ended in Jan. 2026 was $-0.28 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2026 was $0.00 Mil.

QScreen AI's Interest Coverage for the quarter that ended in Jan. 2026 is

QScreen AI had no long-term debt (1).

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

QScreen AI Inc has no debt.

2. Debt to revenue ratio. The lower, the better.

QScreen AI's Debt to Revenue Ratio for the quarter that ended in Jan. 2026 is

Debt to Revenue Ratio=Total Debt (Q: Jan. 2026 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0 + 0) / 0
=N/A

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

QScreen AI has a Z-score of 0.00, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


QScreen AI Business Description

Other Exchanges 3QP:GermanyQAI:Canada
Address 40 King Street West, Suite 2400, P.O. Box 215, Scotia Plaza, Toronto, ON, CAN, M5H 3Y2
QScreen AI Inc is focused on developing artificial intelligence (AI) powered technologies for general workplace health and safety, and for the health care industry. The company's business is focused on artificial intelligence (AI) technologies targeting two specific areas: workplace health and safety and healthcare. It is building a proprietary artificial intelligence engine with quantum inspired computing and physiological sensing to clinical and occupational health assessments across correctional facilities, addiction medicine rehabilitation, and industrial workforce screening in multiple jurisdictions. It operates in single segment.